Silence Therapeutics plc

Silence Therapeutics plc

SLN.L
Silence Therapeutics plcGB flagLondon Stock Exchange
535.00
GBp
-5.00
- -

Silence Therapeutics plc (SLN.L) Stock Split History

Learn about Silence Therapeutics plc's most recent 1-for-50 basis stock split on April 30, 2013. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Silence Therapeutics plc's most recent stock split

Split Date: 2013-04-30
Split Ratio: 1:50
Price Before Split: N/A
Price After Split: N/A

Developer API

Get SLN.L split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/SLN.L

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 50.00 times fewer shares (a 1:50 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Silence Therapeutics plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2013-04-301:50YesN/AN/A

About Silence Therapeutics plc

Company overview and industry information

Silence Therapeutics plc (SLN.L) operates in the Biotechnology industry. The recent 1-for-50 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Silence Therapeutics plc Summary

Last updated: 7/9/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.